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Abstract
During the past century, humans have gained more years of average life expectancy than in the last
10,000 years; we are now living in a rapidly ageing world. The sharp rise in life expectancy, coupled
to a steady decline in birth rates in all developed countries, has led to an unprecedented
demographic revolution characterized by an explosive growth in the number and proportion of
older people. Ageing is a complex process that negatively impacts the development of the immune
system and its ability to function. Progressive changes in the T and B cell systems over the life span
have a major impact on the capacity to respond to immune challenge. These cumulative age-
associated changes in immune competence are termed Immunosenescence: some immunological
parameters are commonly notably reduced in the elderly and, reciprocally good function is tightly
correlated to health status. Hence, a better understanding of Immunosenescence and the
development of new strategies to counteract it are essential for improving the quality of life of the
elderly population.
Background
The "Understanding Aging: Biomedical and Bioengineer-
ing Approaches" conference was held from June 27–29,
2008 at UCLA organized by Aubrey de Grey to discuss and
talk about possible intervention in ageing.
During the past century, mankind has gained more years
of average life expectancy than in the last 10,000 years. We
are now living in a rapidly ageing world. The sharp rise in
life expectancy, coupled to a steady decline in birth rates
in all developed countries, has led to an unprecedented
demographic revolution characterized by an explosive
growth in the numbers and proportion of older persons.
Nowadays, people are living much longer than they used
to and the longer they live, the longer their bodies are
exposed to environmental factors which increase the risk
of age-associated diseases. The reduction of the response
to environmental stimuli is associated with an increased
predisposition to illness and death. This progression
causes a reduction of the response to environmental stim-
uli and, in general, is associated with an increased predis-
position to illness and death. In Western countries, the
mortality rate increases in people over 65 years, if com-
pared with individuals between 25 and 44 years old, by
100-fold for stroke, as well as chronic lung disease, 92-
fold for heart disease, 89-fold for pneumonia and influ-
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enza, 43-fold for cancer [1]. On the contrary, ageing in
good condition seems directly correlated with a good
functioning of the immune system, suggesting that there
are genetic determinants of longevity in genes regulating
the immune inflammatory response [2,3].
In senescence alterations of innate and instructive immu-
nity have been described. The modifications of the
immune system in the elderly are generally evaluated as a
deterioration of the immune system, this is the origin of
the term immunosenescence. A good immune system in
the elderly is tightly correlated to health status, and some
immunological parameters are often notably reduced in
the elderly. On the other hand infectious diseases, tumors,
autoimmune phenomenona and inflammatory chronic
diseases like atherosclerosis and Alzheimer's disease, are
frequent in this phase of the life course [3-5].
A body of experimental and clinical evidence has sug-
gested that the immune system is implicated, with a vari-
able degree of importance, in almost all age related or
associated diseases. Both innate and instructive immune
systems are usually involved in the pathogenesis of these
chronic diseases. However, innate immunity appears to
be the prevalent mechanism driving tissue damages asso-
ciated with different age-related diseases [6]. So, ageing is
accompanied by an age-dependent up-regulation of the
inflammatory response, due to the chronic antigenic stress
that impinges throughout life upon innate immunity, and
has potential implications for the onset of inflammatory
diseases [7].
Here is an extract of the talks and posters presented:
Mitochondrial damage
Perturbation of mitochondrial Fe homeostasis cause a
decline in mitochondrial function that causes neuromus-
cular degenerative disease and other tissue dysfunction. C.
Leeuwenburgh suggested that mitochondrial non-heme
Fe represents a potential novel target for targeted interven-
tions to slow ageing (C. Leeuwenburgh, University of
Florida, USA) [8].
Micronutrient inadequacy
It was proposed that inadequate micronutrient intake
leads to metabolic modification that has long term conse-
quences such as cancer (DNA damage), severe infection
(immune dysfunction) and cognitive dysfunction and
accelerated ageing (mitochondrial decay). Much evidence
supports the idea that micronutrient shortage accelerate
ageing (B.N. Ames, University of California, Berkeley, CA,
USA) [9].
Telomeres
The shortening of telomeres is supposed to be the molec-
ular clock of ageing; indeed there is a strong correlation
between age and telomere length and shorter telomeres
directly correspond to shorter human life expectancy. For
this purpose, several biotech organizations have accepted
the challenge of finding ways to prevent telomere shorten-
ing by transiently inducing the activity of telomerase (L.A.
Briggs, Reno, NV, USA). Another research has shown that
therapy acting on the catalytic component of human tel-
omerase, such as TAT2, a small molecule telomerase acti-
vator, could stabilize the telomere length and retard the
loss of the immune control over viral infection (R. Effros,
UCLA, Los Angeles, CA, USA) [10].
Immunological Point of view
On the immunological side Dr Z. Cui has shown that can-
cer cells in vitro could be killed by the effector cells of the
innate immune system such as macrophages and neu-
trophils. A similar activity was discovered in some healthy
people concerning granulocytes and monocytes (Z. Cui,
Winston-Salem, NC, USA) [11].
According to the fact that the immune system plays an
important role in ageing, the group of Prof. C. Caruso,
actively involved in immunosenescence studies [2-5], has
demonstrated that B naïve lymphocytes, are increased in
the offspring of healthy old centenarians. It has been dem-
onstrated that the children of centenarians, who are in
their 70s and 80s, have a survival advantage when com-
pared with control subject of the same age range whose
parents died at an average life expectancy [3]. The main
lymphocyte differences observed between the two groups
concern B cells. Indeed naïve B cells are more abundant as
well as double negative B cells in centenarian children.
These data are similar to that found in previously experi-
ment on young subjects. So, B cell compartment of the
offspring of centenarians seems to be more similar to that
of young respect to the old one (S. Vasto, University of
Palermo, Italy) [12].
It is well known that change in immune function are hall-
marks of ageing and the group of Dr. A. Agrawal (Univer-
sity of California, Irvine, CA, USA) has shown that the
reactivity of dendritic cells to self-antigens can be charac-
teristic of ageing features. Furthermore, this over-reactivity
induces lymphocyte T proliferation with subsequent
higher risk of autoimmune diseases [13].
Interestingly, Effros's group suggests a possible involve-
ment of hyper-activated T cells in bone loss associated
with vascular disease in aged mice. The increased propor-
tion of CD8 T cells lacking expression of the co-stimula-
tory receptor CD28 leads to decreased vaccine
responsiveness and early mortality [14]. ST Parish foundPublish with BioMed Central    and   every 
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that loss of CD28 expression is caused by increased Cas-
pase-3 activity that can be induced by Tumor necrosis fac-
tor-alpha and suggested possible strategies for retarding
the generation of senescent CD8 T cells during ageing (L.S.
Graham, UCLA, Los Angeles, CA, USA).
Conclusion
Ageing is a complex process that negatively impacts the
development of the immune system and its ability to
function. Progressive changes in the T and B cell systems
over the life span have a major impact on the capacity to
respond to immune challenge. These cumulative age-
associated changes in immune competence are termed
immunosenescence. A better understanding of immu-
nosenescence and the development of new strategies to
counteract it are essential for improving the quality of life
of the elderly population [5]
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